Male adults
Conditions
Interventions
Oral consumption of the test food (2 sachets, once daily) for 4 weeks
Oral consumption of the placebo food (2 sachets, once daily) for 4 weeks
Sponsors
CPCC Company Limited
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. Male aged 20 to below 40 years. 2. Individuals with a body mass index (BMI) of 25.0 kg/m2 or more and less than 30.0 kg/m2. 3. Individuals who are able to give informed consent to participate in this study after receiving a detailed explanation of the protocol and understanding its contents.
Exclusion criteria
Exclusion criteria: 1. Individuals who are following dietary restrictions (e.g., low-carbohydrate diets, vegetarian diets) or have extremely irregular eating habits. 2. Individuals with irregular daily routines, such as shift workers or those who work night shifts. 3. Individuals who regularly consume Foods for Specified Health Uses, Foods with Function Claims, dietary supplements, medications, or quasi-drugs that may affect energy metabolism. 4. Individuals who are currently smoking or who have smoked within the past year. 5. Individuals who consume alcohol at least once a week. 6. Individuals who engage in exercise for 30 minutes or more at least twice per week. 7. Individuals who have participated in another clinical trial within the past 3 months or are currently participating in another clinical trial. 8. Individuals who have been diagnosed with or have a history of severe cardiovascular disease, hepatic dysfunction, renal dysfunction, respiratory disorders, endocrine disorders, or metabolic disorders. 9. Individuals with a history of chest pain or syncope. 10. Individuals with electrocardiographic abnormalities that a physician deems to interfere with exercise. 11. Individuals with low back pain, joint pain, lumbar disc herniation, lower limb disorders, or who experience palpitations during physical exertion. 12. Individuals with known allergies to drugs or foods. 13. Individuals deemed unsuitable for participation in the trial by the principal investigator or sub-investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Indicators related to fat oxidation during exercise (fat oxidation rate and respiratory exchange ratio). | — |
Secondary
| Measure | Time frame |
|---|---|
| Fat oxidation rate and respiratory exchange ratio at rest Carbohydrate oxidation and energy expenditure at rest and during exercise Physical fatigue before and after exercise | — |
Countries
Japan
Contacts
Public ContactMasanori Numa
CPCC Company Limited Clinical Planning Department
Outcome results
None listed